The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening

Neoplasma

Volumn 50, Issue 3, 2003, Pages 217-221

  Shen, Y Y ^a   Su, C T ^a   Chen, G J S ^a   Chen, Y K ^a   Liao, A C F ^a   Tsai, F S ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

18F fluoro 2 deoxy D glucose; Cancer screening; Positron emission tomography; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER;

EID: 0038607785     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ADLER LP, BLAIR HF, MAKLEY JT, WILLIAMS RP, JOYCE MJ, LEISURE G, AL-KAISI N, MIRALDI F. Noninvasive grading of muscloskeletal tumors using PET. J Nucl Med 1991; 32: 1508-1512.
2. AVRIL N, DOSE J, JANICKE F, ZIEGLER S, ROMER W, WEBER W, HERZ M, NATHRATH W, GRAEFF H, SCHWAIGER M. Assessment of axillary lymph node involvement in breast cancer patient with PET using radiolabeled FDG. J Natl Cancer Inst 1996; 88: 1204-1209.
3. DEHDASHTI F, MORTIMER JE, SIEGEL BA, GRIFFETH LK, BONASERA TJ, FUSSELMAN MJ, DETERT DD, CUTLER PD, KATZENELLENBOGEN JA, WELCH MJ. PET assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med 1995; 36: 1766-1774.
4. DEWAN NA, GUPTA NC, REDEPENNING LS, PHALEN JJ, FRICK MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management. Chest 1993; 104: 997-1002.
5. ENOMOTO K, FUKUNAGA T, OKAZUMI S, ASANO T, KIKUCHI T, YAMAMOTO H, NAGASHIMA T, ISONO K, ITOH H, IMAZEKI K. Can fluorodeoxyglucose positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma. Kaku Igaku 1991; 28: 1353-1356.
6. GUERRERO TM, HOFFMAN EJ, DAHLBOM M. Characterization of a whole body imaging technique for PET. IEEE Trans Nucl Sci 1990; 676-680.
7. HOFER C, KUBLER H, HARTUNG R, BREUL J, AVRIL N. Diagnosis and monitoring of urological tumors using positron emission tomography. Eur Urol 2001; 40(5): 481-487.
8. KAO CH, KWAN AS, KWAN JK, CHOW MJ. The role of 18F-fluorodeoxyglucose positron emission tomography in cancer screening - a preliminary report. Oncol Rep 2001; 8: 1145-1148.
9. KUBOTA K, MATSUZAWA T, FUJIWARA T, ITO M, HATAZAWA J, ISIEWATA K, IWATA R, IDO T. Differential diagnosis of lung tumor with PET. J Nucl Med 1990; 31: 1927-1932.
10. LOWE VJ, FLETCHER JW, GOBAR L, LAWSON M, KIRCHNER P, VALK P, KARIS J, HUBNER K, DELBEKE D, HEIBERG EV, PATZ EF, COLEMAN RE. Prospective investigation of PET in lung nodules. J Clin Oncol 1998; 16: 1075-1084.
11. OSHIDA M, UNO K, SUZUKI M, NAGASHIMA T, HASHIMOTO H, YAGATA H, SHISHIKURA T, IMAZEKI K, NAKAJIMA N. Predicting the prognosis of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro [18F]-D-glucose. Cancer 1998; 82: 2227-2234.
12. PATZ EF JR, LOWE VJ, HOFFMAN JM, PAINE SS, BURROWES P, COLEMAN RE, GOODMAN PC. Focal pulmonary abnormalities: evaluation with F18 FDG PET scanning. Radiology 1993; 188: 487-490.
13. POPLACK SP, TOSTESON AN, GROVE MR, WELLS WA, CARNEY PA. Mammography in 53,803 women from the New Hampshire Mammography Network. Radiology 2000; 217: 832-840.
14. PRICE P, JONES T. Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy. Eur J Cancer 1995; 31A: 1924-1927.
15. RIGO P, PAULUS P, KASCHTEN BJ, HUSTINX R, BURY T, JERUSALEM G, BENOIT T, FOIDART-WILLEMS J. Oncological application of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
16. SCHIEPERS C, PENNINCKX F, DE VADDER N, MERCKX E, MORTELMANS L, BORMANS G, MARCHAL G, FILEZ L, AERTS R. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 1995; 21: 517-522.
17. VANSTEENKISTE JF, STROOBANTS SG, DE LEYN PR, DUPONT PJ, VERSCHAKELEN JA, NACKAERTS KL, MORTELMANS LA. Mediastinal lymph node staging with FDG-PET scan in patient with potentially operable non-small cell lung cancer. A prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 1997; 112: 1480-1486.
18. YASUDA S, IDE M, FUJII H, NAKAHARA T, MOCHIZUKI Y, TAKAHASHI W, SHOHTSU A. Application of positron emission tomography imaging to cancer screening. Br J Cancer 2000; 83: 1607-1611.